Morphosys Ag Adr Stock Revenue
MorphoSys AG ADR fundamentals help investors to digest information that contributes to MorphoSys' financial success or failures. It also enables traders to predict the movement of MorphoSys Stock. The fundamental analysis module provides a way to measure MorphoSys' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MorphoSys stock.
MorphoSys |
MorphoSys AG ADR Company Revenue Analysis
MorphoSys' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current MorphoSys Revenue | 238.28 M |
Most of MorphoSys' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MorphoSys AG ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, MorphoSys AG ADR reported 238.28 M of revenue. This is 96.88% lower than that of the Biotechnology sector and 67.93% lower than that of the Health Care industry. The revenue for all United States stocks is 97.47% higher than that of the company.
MorphoSys Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MorphoSys' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MorphoSys could also be used in its relative valuation, which is a method of valuing MorphoSys by comparing valuation metrics of similar companies.MorphoSys is currently under evaluation in revenue category among its peers.
MorphoSys Fundamentals
| Return On Equity | -1.84 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (1.91) % | |||
| Operating Margin | (9.60) % | |||
| Current Valuation | 2.68 B | |||
| Shares Outstanding | 150.65 M | |||
| Shares Owned By Institutions | 7.44 % | |||
| Number Of Shares Shorted | 135.04 K | |||
| Price To Earning | 4.52 X | |||
| Price To Book | 53.81 X | |||
| Price To Sales | 11.83 X | |||
| Revenue | 238.28 M | |||
| Gross Profit | 229.65 M | |||
| EBITDA | (97.74 M) | |||
| Net Income | (189.73 M) | |||
| Cash And Equivalents | 726.83 M | |||
| Cash Per Share | 5.32 X | |||
| Total Debt | 635.93 M | |||
| Debt To Equity | 2.31 % | |||
| Current Ratio | 2.98 X | |||
| Book Value Per Share | (6.96) X | |||
| Cash Flow From Operations | (295.84 M) | |||
| Short Ratio | 2.65 X | |||
| Earnings Per Share | (1.50) X | |||
| Target Price | 15.58 | |||
| Number Of Employees | 464 | |||
| Beta | 0.66 | |||
| Market Capitalization | 2.86 B | |||
| Total Asset | 2.03 B | |||
| Retained Earnings | (1.01 B) | |||
| Working Capital | 549.71 M | |||
| Current Asset | 386.7 M | |||
| Current Liabilities | 48.64 M | |||
| Net Asset | 2.03 B |
About MorphoSys Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MorphoSys AG ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MorphoSys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MorphoSys AG ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with MorphoSys
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MorphoSys position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MorphoSys will appreciate offsetting losses from the drop in the long position's value.Moving against MorphoSys Stock
| 0.84 | MMV | MultiMetaVerse Holdings | PairCorr |
| 0.83 | THCPU | Thunder Bridge Capital | PairCorr |
| 0.77 | OPTX | Syntec Optics Holdings Trending | PairCorr |
| 0.64 | HSDT | Helius Medical Techn | PairCorr |
| 0.52 | XMTR | Xometry | PairCorr |
The ability to find closely correlated positions to MorphoSys could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MorphoSys when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MorphoSys - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MorphoSys AG ADR to buy it.
The correlation of MorphoSys is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MorphoSys moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MorphoSys AG ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MorphoSys can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in MorphoSys Stock
If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |